Image analysis of papillary thyroid carcinoma fine-needle aspirates: Significant association between aneuploidy and death from disease

Cancer

Volumn 87, Issue 3, 1999, Pages 155-160

  Sturgis, Charles D ^a   Caraway, Nancy P ^a   Johnston, Dennis A ^a   Sherman, Steven I ^a   Kidd, Larry ^a   Katz, Ruth L ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

DNA ploidy; Fine needle aspiration; Image analysis; Papillary thyroid carcinoma

Indexed keywords

ADULT; AGED; ANEUPLOIDY; ARTICLE; ASPIRATION BIOPSY; CANCER DIAGNOSIS; CANCER MORTALITY; CELL PROLIFERATION; CLINICAL ARTICLE; DISEASE ASSOCIATION; DNA CONTENT; FEMALE; HUMAN; IMAGE ANALYSIS; MALE; PLOIDY; PRIORITY JOURNAL; THYROID PAPILLARY CARCINOMA;

EID: 0033603629     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-0142(19990625)87:3<155::aid-cncr9>3.0.co;2-%23     Document Type: Article

References (25)

1. Gilliland FD, Hunt WC, Morris DM, Key CR. Prognostic factors for thyroid carcinoma: a population-based study of 15,698 cases from the surveillance, epidemiology and end results (SEER) program, 1973-1991. Cancer 1997;79:564-73.
2. Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics, 1998. CA Cancer J Clin 1998;48:6-29.
3. Treseler PA, Clark OH. Prognostic factors in thyroid carcinoma. Surg Oncol Clin North Am 1997;6:555-99.
4. McLeod MK. The measurement of DNA content and ploidy analysis in thyroid neoplasms. Otolaryngol Clin North Am 1990;23:271-90.
5. Joensuu H, Klemi P, Eerola E, Tuominen J. Influence of cellular DNA content on survival in differentiated thyroid cancer. Cancer 1986;58:2462-7.
6. Hamming JF, Schelfhout LJ, Cornelisse CJ, Van de Velde CJ, Goslings BM, Hermans J, et al. Prognostic value of nuclear DNA content in papillary and follicular thyroid cancer. World J Surg 1988;12:503-8.
7. Tsuchiya A, Sekikawa K, Ando Y, Suzuki S, Kimijima I, Abe R. Flow cytometric DNA analysis of thyroid carcinoma. Jpn J Surg 1990;20:510-4.
8. Mizukami Y, Nonomura A, Michigishi T, Kosaka T, Noguchi M, Nakamura S, et al. Flow cytometric DNA measurement in benign and malignant human thyroid tissues. Anticancer Res 1992;12:2213-8.
9. Yamashita H, Noguchi S, Murakami N, Tsuji K, Yamaoka N, Sakamoto A. DNA ploidy and stromal bone formation as prognostic indicators of thyroid papillary carcinoma in aged patients: a retrospective study. Acta Pathol Jpn 1993;43:22-7.
10. Jonasson JG, Hrafnkelsson J. Nuclear DNA analysis and prognosis in carcinoma of the thyroid gland: a nationwide study in Iceland on carcinomas diagnosed 1955-1990. Virchows Arch 1994;425:349-55.
11. De la Roza G, Hopkovitz A, Caraway NP, Kidd L, Dinney CP, Johnston D. DNA IA of urinary cytology: prediction of recurrent transitional cell carcinoma. Mod Pathol 1996;9: 571-8.
12. Katz RL, Sinkre PA, Zhang HH, Kidd L, Johnston D. Clinical significance of negative and equivocal urinary bladder cytology alone and in combination with DNA image analysis and cystoscopy. Cancer(Cancer Cytopathol) 1997; 81:354-64.
13. DeMay RM. The art and science of cytopathology. Chicago: ASCP Press, 1996:729-34.
14. Livolsi VA. Papillary neoplasms of the thyroid pathologic and prognostic features. Am J Clin Pathol 1992;97:426-34.
15. Rosai J, Carcangiu ML, DeLellis R. Atlas of tumor pathology. 3rd series, fascicle 5. Tumors of the thyroid gland. Washington, DC: AFIP Press, 1992:65-121.
16. Donghi R, Sozzi G, Pierotti MA, Biunno I, Miozzo M, Fusco A, et al. The oncogene associated with human papillary thyroid carcinoma (PTC) is assigned to chromosome 10 q11-q12 in the same region as multiple endocrine neoplasia type 2A (MEN2A). Oncogene 1989;4:521-3.
17. Grieco M, Santoro M, Berlingieri MT, Bongarzone I, Pierotti MA, Della Porta G, et al. PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas. Cell 1990;60:557-63.
18. Taruscio D, Carcangiu ML, Ried T, Ward DC. Numerical chromosomal aberrations in thyroid tumors detected by double fluorescence in situ hybridization. Genes Chromosomes Cancer 1994;9:180-5.
19. Antonini P, Linares G, Gaillard N, Venuat AM, Schlumberger M, Travagli JP, et al. Cytogenetic characterization of a new human papillary thyroid carcinoma permanent cell line (GLAG-66). Cancer Genet Cytogenet 1993;67:117-22.
20. Gerasimov G, Bronstein M, Troshina K, Alexandrova G, Dedov I, Jennings T, et al. Nuclear p53 immunoreactivity in papillary thyroid cancers is associated with two established indicators of poor prognosis. Exp Mol Pathol 1995: 62;52-62.
21. Smith SA, Hay ID, Goellner JR, Ryan JJ, McConahey WM. Mortality from papillary thyroid carcinoma. Cancer 1988;62: 1381-8.
22. Salmon I, Kiss R, Franc B, Gasperin P, Heimann R, Pasteels JL, et al. Comparison of morphonuclear features in normal, benign and neoplastic thyroid tissue by digital cell image analysis. Analyt Quant Cytol Histol 1992;14:47-54.
23. Kashyap V, Kaushik N, Bhambhani S, Das DK, Luthra UK. Supportive role of image analysis and DNA ploidy pattern in the diagnosis of thyroid tumors. Diagn Cytopathol 1992;8: 228-30.
24. Cusick EL, MacIntosh CA, Krukowski ZH, Ewen SW, Matheson NA. Comparison of flow cytometry with static densitometry in papillary thyroid carcinoma. Br J Surg 1990;77: 913-6.
25. Cohn K, Backdahl M, Forsslund G, Auer G, Lundell G, Lowhagen T, et al. Prognostic value of nuclear DNA content in papillary thyroid carcinoma. World J Surg 1984; 8,474-80.